ozone therapy

Cintas Corporation today declared it has focused on fundraising for the American Heart Association.

Cintas commits fundraising for AHA programs to market heart health awareness In recognition of American Center Month, Cintas Corporation today declared it has focused on fundraising for the American Heart Association , as part of its MEDICAL & Safety Division’s efforts to raise awareness about heart health. As the biggest service provider of CPR, AED and medical training produced by the AHA, Cintas is usually applying company-wide initiatives to improve funds surrounding various AHA events, including Go Crimson for Women, Start! and AHA nation-wide heart walks. An average of 2,300 Americans die of coronary disease each day – one death every 38 mere seconds, added Nancy Wolff, Executive Director Dallas Division, American Cardiovascular Association. Continue reading

One of the leading factors behind cancer loss of life in the global world.

Angiotensin arrests lung tumor growth by inhibiting blood vessel formation In fresh animal research carried out by investigators at Wake Forest University School of Medicine, scientists can see cure effective in mice at blocking the growth and shrinking the size of lung cancer tumors, one of the leading factors behind cancer loss of life in the global world. The study, published in Molecular Cancer Therapeutics recently, a journal of the American Association for Cancer Research, is the first to show that treatment with a specific peptide, angiotensin-, reduces lung tumor growth by inhibiting blood vessel formation propranolol 10 mg blood pressure . Continue reading

MEA News & Events

MEA LAUNCHES EXPANSION INTO CHINA'S HEALTHCARE MARKETPLACE

MedEd Architects announced the launch of a series of on-going educational programs specifically targeted to reach as many as 2.6 million Chinese physicians. The series includes live symposia and web-based programs developed in partnership with renowned US -based medical centers and leading Chinese medical societies. Programs will be accessed through a branded web portal designed to generate awareness of new treatment choices among Chinese physicians.